| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Homology Medicines, Inc. | Director | Option (Right to Buy) | 18,000 | $241,560 | $13.42 | 15 Jun 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PMN | ProMIS Neurosciences Inc. | 07 Jul 2022 | 0 | $0 | 3 | Director | 07 Jul 2022, 19:27 |
| QTTB | Homology Medicines, Inc. | 15 Jun 2022 | 1 | $0 | 4 | Director | 17 Jun 2022, 16:05 |
| QTTB | Homology Medicines, Inc. | 17 Jun 2021 | 1 | $0 | 4 | Director | 22 Jun 2021, 17:41 |